In today’s manufacturing landscape, which is rapidly undergoing digital transformation, Manufacturing Execution Systems (MES) are essential for driving operational excellence, regulatory compliance, and real-time visibility in process and batch operations. Especially in highly regulated sectors like biotech and pharmaceuticals, MES platforms serve as a critical layer for orchestrating complex production workflows and ensuring data integrity across the plant floor.

In the recently released SPARK Matrix™ for Manufacturing Execution Systems – Process and Batch, 2024 by QKS Group (formerly Quadrant Knowledge Solutions), Emerson has been named as a Leader. The report provides a comprehensive analysis of global MES vendors, market trends, and strategic differentiators, along with the SPARK Matrix visual framework evaluating vendors on technology excellence and customer impact.

Evaluation Criteria for Manufacturing Execution Systems – Process and Batch Manufacturing.

The QKS SPARK Matrix assesses MES solutions based on their ability to meet the evolving demands of batch-centric and process-intensive industries. Key evaluation areas include:

• Recipe Management: Centralized and flexible recipe authoring aligned with ISA-88 standards, supporting both master and control recipes. Enables precise execution of validated processes with full traceability and version control, and ensures compliance in regulated industries such as pharmaceutical manufacturing.
• Weighing and Dispensing: Integrates electronic scales with MES to guide operators through validated weighing workflows. Supports room and container checks, tare operations, and real-time verification of material ID and batch information. Displays integrated weight on-screen, decrements source containers, and prints traceable labels for both source and destination containers, ensuring precise material dispensing and compliance with batch specifications.
• Production Orchestration & Scheduling: Executes ERP-defined production schedules based on planned start and end times and enables integration with real-time scheduling systems for dynamic batch sequencing. Supports rule-based workflow execution and task enforcement aligned with plant constraints, including resource availability, demand shifts, and quality requirements.
• Quality & Compliance Management: Embedded procedural enforcement, deviation handling, and generation of electronic batch records (EBR) that comply with GMP, FDA 21 CFR Part 11, and other global regulatory standards.
• Analytics & Decision Support: Provides role-based dashboards and contextualized data views to monitor KPIs such as yield, batch cycle time, and process exceptions. When integrated with business intelligence tools, it supports deeper analysis and predictive insights. Real-time visibility into deviations, particularly within quality workflows, enables faster corrective action. Personalized workspaces further empower users to act on insights relevant to their operational role.
• System Integration & Interoperability: Comprehensive integration with DCS, ERP, SCADA, and LIMS systems to support enterprise-wide synchronization of production and inventory data.

QKS Group Names Emerson a Leader in SPARK Matrix, 2024

Emerson’s leadership positioning in the SPARK Matrix reflects its sustained innovation, deep domain expertise in life sciences, and strong alignment with the digital transformation goals of pharmaceutical manufacturers.

Emerson’s MES Solutions for the Pharmaceutical Industry

Emerson delivers its MES capabilities through the DeltaV™ Manufacturing Execution System, which is tailored to the stringent needs of pharmaceutical and biotech production.

Emerson’s MES offers a comprehensive, flexible, and GMP-compliant framework that addresses key biotech and pharmaceutical manufacturing needs:

• Recipe Authoring and Management: Allows creation, modification, and approval of recipes with full regulatory compliance and alignment to batch production records.
• Weighing & Dispensing Workstations: Streamlines material staging and dispensing with integrated scales, barcode scanning, and automated data capture to ensure right-first-time execution.
• Electronic Batch Records (EBR): Ensures complete traceability and real-time compliance reporting, reducing paper-based documentation and audit risks.
• Integrated Workflows: Coordinates human and automated tasks, from raw material reception to enforcement of equipment and material status checks, to final product packaging, increasing efficiency and minimizing process variability.

With deep integration to Emerson’s DeltaV Distributed Control System and support for enterprise-wide deployments, DeltaV MES provides robust scalability, enhanced security, and cloud-enabled data visibility. Emerson also supports Microsoft Azure-based cloud architectures and deployments, empowering pharmaceutical manufacturers to accelerate digital maturity while meeting regulatory obligations.

Conclusion

As biotech and pharmaceutical companies face mounting pressure to digitize, comply, and optimize, Emerson’s DeltaV MES solution provides a trusted foundation for batch process excellence. Its recognition as a Leader in QKS Group’s SPARK Matrix for Manufacturing Execution Systems – Process and Batch, 2024, reaffirms its commitment to innovation, compliance, and operational agility in biotech and pharmaceutical manufacturing. With core capabilities like recipe management, electronic weighing, materials and inventory management, equipment tracking, electronic batch records, and seamless plant-to-enterprise integration, Emerson stands out as a digital partner of choice for biotech and pharmaceutical manufacturers worldwide.

Visit the DeltaV Manufacturing Execution Systems section on Emerson.com for more information on driving improved manufacturing performance.